IL134778A0 - Pharmaceutical compositions for oral administration of molecular iodine - Google Patents

Pharmaceutical compositions for oral administration of molecular iodine

Info

Publication number
IL134778A0
IL134778A0 IL13477898A IL13477898A IL134778A0 IL 134778 A0 IL134778 A0 IL 134778A0 IL 13477898 A IL13477898 A IL 13477898A IL 13477898 A IL13477898 A IL 13477898A IL 134778 A0 IL134778 A0 IL 134778A0
Authority
IL
Israel
Prior art keywords
iodine
mammal
molecular iodine
molecular
pharmaceutical compositions
Prior art date
Application number
IL13477898A
Other languages
English (en)
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of IL134778A0 publication Critical patent/IL134778A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL13477898A 1997-10-29 1998-10-21 Pharmaceutical compositions for oral administration of molecular iodine IL134778A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (1)

Publication Number Publication Date
IL134778A0 true IL134778A0 (en) 2001-04-30

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13477898A IL134778A0 (en) 1997-10-29 1998-10-21 Pharmaceutical compositions for oral administration of molecular iodine

Country Status (17)

Country Link
US (1) US5885592A (cg-RX-API-DMAC7.html)
EP (1) EP1024815B1 (cg-RX-API-DMAC7.html)
JP (1) JP4187410B2 (cg-RX-API-DMAC7.html)
KR (1) KR100412219B1 (cg-RX-API-DMAC7.html)
CN (1) CN1150904C (cg-RX-API-DMAC7.html)
AT (1) ATE231725T1 (cg-RX-API-DMAC7.html)
AU (1) AU750627B2 (cg-RX-API-DMAC7.html)
BR (1) BR9812588A (cg-RX-API-DMAC7.html)
CA (1) CA2301503C (cg-RX-API-DMAC7.html)
DE (1) DE69811105T2 (cg-RX-API-DMAC7.html)
DK (1) DK1024815T3 (cg-RX-API-DMAC7.html)
ES (1) ES2191973T3 (cg-RX-API-DMAC7.html)
IL (1) IL134778A0 (cg-RX-API-DMAC7.html)
NO (1) NO20001673L (cg-RX-API-DMAC7.html)
PT (1) PT1024815E (cg-RX-API-DMAC7.html)
RU (1) RU2213564C2 (cg-RX-API-DMAC7.html)
WO (1) WO1999021567A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
CA2317587A1 (en) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Solid iodophor preparations and process for producing the same
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
ATE497351T1 (de) * 2003-06-20 2011-02-15 Hills Pet Nutrition Inc Verfahren für die schilddrüsenüberfunktion bei der katze sowie zusammensetzungen mit eingeschränktem jodgehalt
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
JP5356831B2 (ja) * 2006-01-26 2013-12-04 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド ネコ科動物の甲状腺機能亢進症を治療するための方法及び組成物
CN101489411A (zh) * 2006-05-12 2009-07-22 希尔氏宠物营养品公司 用于预防或治疗具有甲状腺机能亢进的猫科动物的慢性肾衰竭的组合物和方法
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CA2656608C (en) * 2006-07-03 2014-09-16 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
US20140072598A1 (en) * 2011-05-16 2014-03-13 Shokan Sabirkhanovich Begaliev Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技(潍坊)有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
WO2015120458A1 (en) * 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
SG11201607686VA (en) 2014-03-31 2016-10-28 Iotech International Inc Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
CA3031447A1 (en) 2016-07-21 2018-01-25 Iogen, Llc Emollient topical disinfectants
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
WO2021198938A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー 癌または子宮内膜症の患者における癌、子宮内膜症および疼痛の治療のためのジイソプロピルアミン化合物およびヨウ素
BR112023001995A2 (pt) 2020-08-13 2023-02-28 I2Pure Corp Composições de alta concentração de iodo molecular, formulações farmacêuticas, preparação e usos
US20240350534A1 (en) * 2020-12-12 2024-10-24 Iocure, Inc. Iodine delivery compounds
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
JP2003510243A (ja) 2003-03-18
NO20001673L (no) 2000-05-24
JP4187410B2 (ja) 2008-11-26
EP1024815B1 (en) 2003-01-29
KR20010030861A (ko) 2001-04-16
KR100412219B1 (ko) 2003-12-24
CA2301503A1 (en) 1999-05-06
CN1150904C (zh) 2004-05-26
AU1122799A (en) 1999-05-17
DK1024815T3 (da) 2003-05-19
PT1024815E (pt) 2003-06-30
US5885592A (en) 1999-03-23
BR9812588A (pt) 2000-07-25
DE69811105T2 (de) 2003-11-06
ATE231725T1 (de) 2003-02-15
ES2191973T3 (es) 2003-09-16
NO20001673D0 (no) 2000-03-31
CA2301503C (en) 2005-01-04
RU2213564C2 (ru) 2003-10-10
DE69811105D1 (de) 2003-03-06
WO1999021567A1 (en) 1999-05-06
CN1272789A (zh) 2000-11-08
AU750627B2 (en) 2002-07-25
EP1024815A1 (en) 2000-08-09

Similar Documents

Publication Publication Date Title
NO20001673D0 (no) Farmasøytiske blandinger for oral administrering av molekylært iod
EP0699072A4 (en) IRON-BINDING POLYMERS FOR ORAL ADMINISTRATION
EP1001772A4 (en) IMPROVEMENTS IN THE ADMINISTRATION OF MULTIPLE DRUG DOSAGES
GEP20022784B (en) Celecoxib Composition
PT906106E (pt) Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca)
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
SI0770384T1 (en) Solid, anhydrous, pharmaceutical compositions for vaginal use
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
AU628095B2 (en) Chelants possessing ortho ligating functionality and complexes thereof
AU2855099A (en) Remedies for hepatitis
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
AUPP325398A0 (en) Improved method for eradicating h. pylori
SE8701077D0 (sv) Pharmaceutical composition
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
UA28031C2 (uk) Лікарська форма похідних 5- нітроімідазолу, фармацевтична композиція для лікування паразитарних та інфекційних захворювань шлунково-кишкового тракту, гастрозахищені мікрогранули похідних 5-нітроімідазолу, мікрогранули поkідних 5-нітроімідазолу з пролонгов
GR3007110T3 (cg-RX-API-DMAC7.html)
YU28700A (sh) Upotreba potencijatora osetljivosti na insulin u proizvodnji leka za lečenje hiperglikemije
DK1019066T3 (da) Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand
CA2197139A1 (en) A drug for the treatment of cancer
AU1305999A (en) (+)-ephedrine as a sympathomimetic drug
UA10436A (uk) Спосіб лікуваhhя виразкової хвороби шлуhку та дваhадцятипалої кишки
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
UA22191A (uk) Спосіб корекції моторhої фуhкції шлуhка і дваhадцятіпалої кишки після резекції шлуhка і ваготомії
TW357092B (en) Transport of solid medicament components

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees